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Abstract
Many living organisms have biological clocks known as circadian rhythms that control
various physiological and behavioral processes, tailored with the day and night. At the cellular
level, the circadian clock drives daily rhythms with a transcriptional-translational feedback loop
(TTFL) established by multiple transcription factors and genes under their regulation. Circadian
Locomotor Output Cycles Kaput (CLOCK) and Brain and Muscle ARNT-like protein 1 (BMAL1)
are two of those transcription factors, initiating the TTFL by forming a heterodimeric complex that
bind to DNA promoters. Neuronal PAS domain protein 2 (NPAS2) is a functional analog to
CLOCK. Less knowledge about NPAS2, in contrast to CLOCK, is available, hindering our
understanding of its roles in the circadian rhythm. To study human NPAS2, large amounts of
recombinant protein were expressed in bacterial systems and purified using various liquid
chromatography techniques. Dynamic light scattering, circular dichroism, and size-exclusion
chromatography were used to characterize the recombinant human NPAS2. Abnormal rhythms
attributed to NPAS2 have been associated with mental illnesses and certain types of cancer. The
characterization of NPAS2 will deepen our understanding of its functions in the circadian rhythm
and will facilitate the design of therapeutic treatments targeting circadian related disorders.
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Chapter 1 Introduction
1.1 The Circadian Rhythm
In many living organisms, the circadian rhythm is an intrinsic biological clock with cycles
of approximately 24 hours, which have evolved to the Earth’s rotation on its axis. It can be traced
back 2.5 billion years to the first simple molecular clock appearing in cyanobacteria1. In 1729,
French astronomer Jean Jacques d'Ortous de Mairan recorded the first observations of the circadian
rhythm in the mimosa plant2. Then in the 1930s, German biologist Erwin Bunning measured the
leaf movement of a bean plant to an almost 24-hour period synchronized to the day and night. With
the help of recombinant DNA technology, the Drosophila period was the first circadian gene to
be cloned and characterized in the 1970-1980s by Jeffrey C. Hall, Michael Rosbash, and Michael
W. Young, independently, leading to the 2017 Nobel Prize in Medicine2. More and more circadian
genes were later identified and studied, with which a molecular mechanism was proposed as the
transcriptional-translational feedback loop (TTFL) (Figure 1.1)3,4.
The TTFL is formed by a network of transcription factors and genes under their regulation.
To start the TTFL, two of those transcription factors, Circadian Locomotor Output Cycles Kaput
(CLOCK) and Brain-Muscle ARNT-like protein 1 (BMAL1) heterodimerize. Then, the
CLOCK/BMAL1 complex binds to E-Box DNA elements to activate the transcription of many
circadian related genes including, period (Per) and cryptochrome (Cry). In turn, the accumulation
of Per and Cry mRNA leads to the translation and formation of PER/CRY complexes in the
cytosol5. After a time-delay to reach a concentration threshold, these complexes translocate to the
nucleus to repress the function of CLOCK/BMAL1, inhibiting the transcription of Per and Cry.



In this thesis, italicized and all-capitalized words will be used to refer to genes and proteins, respectively.
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These inhibitions continue during the night until the PER/CRY complexes themselves are
sufficiently degraded by an ubiquitin-proteasome system6. The TTFL sustains this cycle with a
periodicity of approximately 24 hours7.
In multi-cellular organisms, every individual cell has its own TTFL-controlled circadian
rhythm that needs to be synchronized at the body level. In mammals, the master clock is located
in the suprachiasmatic nucleus (SCN) of the hypothalamus8. This central pacemaker regulates and
entrains peripheral clocks with the input of external environmental stimuli known as zeitgebers8.
The predominant zeitgeber to the master clock is light9. Light signals are perceived by
photoreceptors in the eye which are then transferred via the retino-hypothalamic tract (RHT) to
the SCN9. When responding to light signals, the SCN utilizes neurotransmitters to synchronize the
circadian rhythms of peripheral cells10.
Despite many years of circadian rhythm study, the details of its molecular mechanism are
still elusive. For example, it is unclear whether DNA binding of CLOCK/BMAL1 occurs
rhythmically or if the complex remains bound throughout the entire circadian cycle. The
mechanism of how PER/CRY inhibits the function of CLOCK/BMAL1 also requires further
investigation. The structures of CLOCK/BMAL1 complexed with DNA11 and PER complexed
with the C-terminal of CRY12,13 have been determined, which have deepened our knowledge of
the molecular mechanism of the circadian rhythm. However, there is no high-resolution structural
information on other circadian complexes. Structural and functional studies of the circadian
proteins will provide insights and fill the current gap of knowledge.
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Figure 1.1 The schematic diagram of the transcriptional-translational feedback loop (TTFL).
Circadian Locomotor Output Cycles Kaput (CLOCK) or Neuronal PAS domain protein 2
(NPAS2) heterodimerize with Brain-Muscle ARNT-like protein 1 (BMAL1) to induce the
transcription of many circadian genes including, three period (Per1, Per2, and Per3) and two
cryptochrome (Cry1 and Cry2) genes. In turn, the accumulation of the PER/CRY complexes
translocate into the nucleus to repress the function of CLOCK/BMAL1 (or NPAS2/BMAL1).

1.2 The bHLH-PAS Protein Domain
Multiple Per-ARNT-Sim (PAS) domains are found in CLOCK, BMAL1, and PER
proteins. The PAS domain consists of ∼130 amino acids and has also been observed in signal
transduction proteins that sense environmental signals like oxygen, light, voltage, redox potential,
and even small toxic aromatic molecules14,15. The PAS domain has a conserved structure that
comprises of a five-stranded antiparallel β-sheet with several α-helices flanking it (Figure 1.2)15.
In CLOCK and BMAL1, the DNA-binding regions have additional basic helix-loop-helix (bHLH)
domains at the N-terminal regions of their PAS domains. The bHLH-PAS domain is usually found
in the N-terminal region of proteins with highly conserved structures whereas the C-terminal
regions have various sequences and flexible structures16.

3

Figure 1.2 The structures of bHLH–PAS domains in murine CLOCK (PDB 4F3L). Murine
CLOCK has two PAS domains, denoted as PAS-A and PAS-B. Their structure is presented as a
ribbon diagram together with the bHLH domain in the N-terminal region. The bHLH, PAS-A,
PAS-B, and linker regions are colored in cyan, yellow, orange, and green, respectively. The ribbon
diagram was generated using the UCSF Chimera program17.

The bHLH-PAS domain has been observed in many proteins with limited structural
information on their role in multiprotein complexes18. For example, in addition to the
CLOCK/BMAL1 complex, the bHLH-PAS domain has also been observed in another heterodimer
found in the hypoxia pathway as a response to low oxygen in the cellular environment18. This
heterodimer is formed between hypoxia inducible factor alpha (HIF-α) and aryl hydrocarbon
receptor nuclear translocator (ARNT)19. It is noteworthy that both CLOCK/BMAL1 and
HIF-α/ARNT bind E-box DNA elements, indicating a common molecular mechanism among
different signal-transduction pathways16,18.

1.3 NPAS2
Neuronal PAS domain protein 2 (NPAS2, also termed MOP4) is another circadian protein
that was first characterized in 1997 by Yu-Dong Zhou et al. as a mammalian protein, when it was
sequenced and added to the bHLH-PAS family20. In murine NPAS2, a similar flexible region to
the ARNT PAS-B domain has been found in the six-residue long HI loop connecting the Hβ and
4

Iβ strands. This flexible region has also been observed in Drosophila PER, and in the contact region
between CLOCK and CRY proteins18,21. Based on sequence homology analysis, NPAS2 was
predicted as a functional analog of CLOCK. Furthermore, its classification in the bHLH-PAS
family suggested that NPAS2 could serve as a gene regulatory protein like CLOCK20. Later,
NPAS2 was shown to have a similar function to CLOCK when the circadian rhythmicity in the
SCN was maintained in CLOCK-deficient animals22. Real-time PCR results have shown that
Npas2 is expressed within the SCN. Without CLOCK, NPAS2 can keep the SCN clockwork
maintained with no interference from other brain regions22.
Interestingly, there has been contradicting results on whether NPAS2 can regulate the
circadian rhythm in peripheral tissues or not. Some studies showed that NPAS2 can maintain the
circadian clock only in the SCN, while others present results indicating that NPAS2 can substitute
CLOCK in peripheral cells in certain tissues22,23. A hypothesis regarding why NPAS2 cannot
perform its job in other tissues was raised that a molecular ligand with or without its receptor might
be present in the SCN that is not found in peripheral clocks or vice-versa22. Overall, further
investigation is needed to prove or disprove this hypothesis. Also, it is unknown how the
overlapping function of NPAS2 with CLOCK helps the master clock in the SCN. It could either
be a genetic compensation or simply a redundant mechanism22. Others suggested the overlapping
roles of both proteins could provide the circadian pathway an ability to function in a tissue specific
manner5.

1.4 Binding to Heme and the Effect of CO on NPAS2 Function
Besides the bHLH-PAS domain, a heme binding motif was observed in NPAS2, which can
inhibit the DNA binding of the NPAS2/BMAL1 transcription complex in response to carbon
monoxide (CO)24. The CO is generated during heme degradation by oxygenases24. An in vitro
5

study showed that without CO, NPAS2 and CLOCK can continue DNA binding in the murine
liver and promote transcription of E-box-controlled circadian genes (Per1, Per2, Cry1, Cry2, and
Rev-erbα)25. While heme is bound to the NPAS2/BMAL1 complex, the increase in concentration
of CO dissociates NPAS2 from E-box DNA elements25. This suggests that endogenous CO has an
interfering role in the regulation of the TTFL25.

1.5 The Role of NAD and SIRT1
As described in Section 1.4, besides generating CO, heme degradation also consumes
NADPH25. The reducing cofactors, NADH and NADPH, have been shown to enhance DNA
binding of CLOCK/BMAL1 in vitro, whereas their oxidized forms have the reverse effects4.
However, the stronger reducing agent, DTT, did not produce the inhibition, suggesting that NAD
works as a molecular ligand rather than changing the redox states26. More studies revealed NAD
functions as a circadian metabolite by promoting Sirtuin 1 (SIRT1) to interfere with DNA
binding11,27,28. SIRT1, a nicotinamide adenosine dinucleotide (NAD)-dependent deacetylase, alters
the expression of circadian rhythm-associated genes through their deacetylation, including Bmal1,
Npas2, Clock, and Per229,30, thus showing another pathway where NAD can affect the circadian
rhythm with or without NPAS2.

1.6 NPAS2 Related Diseases
Sleep deprivation and jetlag caused by circadian rhythm disruption can lead to the
degeneration of neurons in the brain31. It has also been found that shift workers have developed
cognitive impairment, as well as metabolic and mental illness32. Npas2 is highly expressed in brain
regions such as the striatum that are responsible to process the reward- and stress-response33.
Abnormal rhythms attributed to NPAS2 have been linked to psychiatric illnesses like seasonal
affective disorder, bipolar disorder, and depression33.
6

In addition, Npas2 could be a potential biomarker for cancers such as colorectal and breast
cancer due to its association with tumor initiation and progression34,35. Nevertheless, it is unclear
how Npas2 affects cancer cell survival. One study on hepatocellular carcinoma have shown an
upregulation of Npas2 which is believed to facilitate cell survival both in vitro and in vivo36.
However, the regulation of Npas2 expression in cancer is tumor type specific36.

1.7 Circadian Rhythm Research and Health
Because the circadian rhythm is linked to many pathologies, it is an important therapeutic
target in pharmacological research. One focus is to find small molecules that can bind to circadian
proteins to alter circadian rhythms37. Another approach aims at chrono-pharmacology and its
compelling benefits. Some diseases have flares at certain times of the day 7. Several enzymes and
transporter proteins that are involved in drug metabolism show circadian oscillations.
Understanding the mechanism behind chrono-pharmacology can help design appropriate time
scheduled drug treatments with higher efficacy38.
As mentioned in Section 1.3, NPAS2 is mainly expressed in the master clock located in
the SCN. It is also related to many mental diseases and certain cancers (Section 1.6). The
characterization of this circadian regulator holds a great importance. It will uncover essential
knowledge about the role of NPAS2 in the SCN and build the foundation for developing
therapeutic treatments in circadian related diseases.

7

1.8 Specific Aims
Aim 1) Expression and purification of recombinant human NPAS2 (hNPAS2)
To characterize hNPAS2, large amounts of homogenous protein is needed. Human Npas2
has been cloned and expressed in bacterial systems with tags for improving solubility and
purification. hNPAS2 was also co-expressed with molecular chaperones to further improve
protein folding. Multiple techniques were used to purify the recombinant hNPAS2.
Aim 2) Characterization of recombinant hNPAS2
Recombinant hNPAS2 has been characterized using various biochemical and biophysical
techniques, including size exclusion chromatography, dynamic light scattering, and circular
dichroism.
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Chapter 2 Materials and Methods
2.1 Gene Cloning of hNpas2 gene into a pColdTF Expression Vector
Gene cloning was carried out by Karla Moriel, a former member of the group. The hNpas2
gene was codon optimized for bacterial expression by GenScript Biotech with additional codons
for 6xHis tag at the 3’ end of the gene. The synthesized gene was cloned into a pColdTF vector
(Takara Bio USA Inc.) by digestion of both synthesized gene and vector using restriction
endonucleases NdeI and XhoI (NEB, cat. #R0111S and R0146S). The digested hNpas2 insertion
was ligated overnight with the vector using T4 DNAse Ligase Reaction Buffer (NEB, cat.
#B0202S). The resulting ligated product was transformed into E. coli Mach1 (Thermo Fisher, cat.
# C862003) competent cells for plasmid purification using the Qiagen Plasmid Purification Kit
(Qiagen, cat #12943). The sequence of the plasmid was verified using a DNA sequencer at the
Border Biomedical Research Center (BBRC) of The University of Texas at El Paso. The pColdTF
expression system includes the bacterial trigger factor (TF) at the N-terminal of the inserted
recombinant protein. The TF (48kDa) is a bacterial chaperone that was fused to the recombinant
hNPAS2 to facilitate protein folding and solubility, whereas the His tag was included for the
affinity purification.

2.2 Co-Transformation with pKJE7
The purified TF-hNPAS2 plasmid was co-transformed with a pKJE7 (Takara, cat. #3340)
chaperone plasmid into E. coli BL21 (DE3) competent cells (NEB, cat #C2527I). The pKJE7
chaperone plasmid contains genes coding for multiple chaperones, including DNAK (~70kDa),
DNAJ (~40kDa), and GRPE (~22kDa). The co-expression of these chaperones was utilized to
improve the protein folding of recombinant TF-hNPAS2.

9

2.3 Expression of recombinant TF-hNPAS2
Individual colonies of the co-transformed cells from Section 2.2 were picked to grow
starter cultures in 25ml of TB media (Fisher Scientific, cat. #BP97285) containing 100µg/ml and
34µg/ml final concentration of ampicillin (GoldBio, cat. #A-301) and chloramphenicol (GoldBio,
cat. #C-105), respectively. They were incubated overnight for ~14h at 37°C with 260rpm shaking.
Large-scale cultures were grown with a 1:200 dilution of starter culture. The media contained
100µg/ml, 34µg/ml, and 1mg/ml final concentration of ampicillin, chloramphenicol, and Larabinose (GoldBio, cat. #A-300), respectively. L-arabinose was added to the culture as an inducer
of the chaperone expression from the pKJE7 plasmid. Once the OD600 of 1.0 was reached, the
shaking was stopped, and the temperature was reduced to 15°C to activate the transcription using
the cold-shock promoter of the pCOLDTF plasmid. Additional L-arabinose was added to increase
its final concentration by 1mg/ml. Once the temperature settled to 15°C, the cultures were induced
with 1mM IPTG and the shaking was re-started at 260rpm. Protein was expressed for 2h. SDSPAGE and western blot were used to confirm the expression.

2.4 Purification of Recombinant TF-hNPAS2
2.4.1 Cell Lysis
The bacterial cultures were collected and centrifuged at 4,696xg for 20min. The
supernatant was removed, and the pellet was weighed. Each 0.1g of pellet was resuspended in 1ml
of lysis buffer (20mM Tris-HCl pH 8.0, 500mM NaCl, 5mM DTT, 10mM MgCl2, and 0.02%
NaN3). Due to the fact that DTT hinders circular dichroism (CD) analyses, it was removed from
the buffers in later purifications. After adding PMSF and lysozyme to the final concentration of
1mM and 25µg/ml, respectively, the lysate was incubated at room temperature for 20min with
gentle rocking. The lysate was then frozen and stored at -80°C.
10

Frozen lysate (~200ml) was thawed and additional PMSF was added to increase the final
concentration by 1mM. The lysate was sonicated on ice for 4 trials of 7sec with time breaks of
3min. Together with the lysozyme, the sonication further broke the bacterial cell wall to release
the recombinant protein. The sample was then incubated with DNase and MgCl2 to the final
concentration of 20μg/ml and 10mM, respectively, for 10 minutes. Finally, cell debris was
removed by centrifugation at 44,000xg and the supernatant was filtered through 0.2µm filters prior
to affinity purification.

2.4.2 Affinity Chromatography
A 5ml HisTrap HP affinity chromatography column (GE, cat. #17371205) was preequilibrated with buffer A (20mM Tris–HCl pH 8.0, 500mM NaCl, and 0.02% NaN3). The lysate
of the recombinant TF-hNPAS2 was loaded to the column with a flowrate of 1ml/min. The column
was washed with buffer A until the UV absorption stabilized to its lowest value. The column was
further washed using a step gradient of 10mM, 20mM, and 40mM imidazole generated by mixing
buffer A with buffer B (20mM Tris–HCl pH 8.0, 500mM NaCl, 500mM imidazole, and 0.02%
NaN3) at different ratios. The bound proteins were eluted at 60mM, 120mM and 250mM imidazole
generated as mentioned above. These three fractions will be analyzed throughout this thesis as
affinity fractions, AF60, AF120, and AF250. Fractions of the purification process were collected
and examined with SDS-PAGE.

2.4.3 Anion-exchange Chromatography (AEX)
The PI of TF-hNPAS2 was estimated to be 5.62 using the ExPASy online tool39, suggesting
that the protein will strongly bind to a positively charged resin at pH 840. Therefore, an anionexchange purification was performed to further purify the recombinant protein. Before the ionexchange chromatography, the AF60, AF120, and AF250 from the affinity purification were buffer
11

exchanged to a desalting buffer (20mM Tris-HCl pH 8.0, 100mM NaCl, and 0.02% NaN3) using
a HiPrep 26/10 column (Sigma, cat. #17-5087-01). At a flowrate of 1ml/min, the desalted samples
from the AF60 and AF120 were combined and loaded to a 5ml HiTrap Q HP anion-exchange
column (GE, cat. #17-1153-01) pre-equilibrated with the same desalting buffer. A trial experiment
was performed to elute the bound protein using a continuous gradient generated by mixing the
desalting buffer with an AEX buffer (20mM Tris–HCl pH 8.0, 1M NaCl, and 0.02% NaN3) at a
continuously changing ratio. From this trial experiment, the recombinant TF-hNPAS2 was
observed to mainly elute at a calculated concentration of NaCl between 253mM and 325mM. In
the final AEX experiment, the bound protein was eluted in a step-gradient of 253mM, 298mM,
and 505mM NaCl, generated with the AEX buffer. These three fractions will be analyzed
throughout this thesis as AEX fractions, AEX253, AEX298, and AEX505. Fractions collected
were examined on SDS-PAGE and subjected to bicinchoninic acid assay (BCA) (Thermo
Scientific, cat. # 23225) to measure the concentration of the protein.

2.5 Characterization of Recombinant TF-hNPAS2
2.5.1 Size-Exclusion Chromatography (SEC)
The molecular weight of recombinant TF-hNPAS2 was analyzed by a Superdex 200
10/300 SEC column (GE, cat. #17-5175-01). The column was pre-equilibrated with SEC buffer
(20mM Tris-HCl pH 8.0, 100mM NaCl, 2mM DTT, 10mM MgCl2, and 0.02% NaN3). For each
SEC, 300µl of AF samples without desalting were loaded. The individual peaks were collected
and examined by SDS-PAGE.
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2.5.2 Dynamic Light Scattering (DLS)
DLS spectra were measured using a Zetasizer Nano S (Malvern) instrument set at 4°C. For
each measurement, 500µl of the protein samples were added to disposable cuvettes (Plastibrand,
cat. #759075D) with a 1.0cm pathlength. The size data was averaged from 3 cycles of 11 iterations.
The sample concentrations were ~0.160mg/ml and ~0.242mg/ml for desalted AF samples and
AEX samples, respectively. A separate salt-addition test was performed on the AEX253 sample to
test whether adding NaCl would change the size of the recombinant protein. The NaCl
concentration was increased to 428mM and 605mM by adding filtered 2M NaCl. These samples
were incubated on ice with gentle rocking for 20min before DLS measurement. The sample with
605mM NaCl was left at 4°C for a longer incubation period of 3 days prior to another DLS
measurement.

2.5.3 Circular Dichroism (CD)
A J-1500 CD spectrophotometer (JASCO) was utilized to measure far-UV CD spectra of
the recombinant TF-hNPAS2. The AEX298 sample was diluted to 149mM NaCl with Tris buffer
(20mM Tris-HCl pH 8.0) and concentrated to ~0.46mg/ml (3.3µM). The CD measurement
parameters are listed on Table 2.1 and the desalting buffer (Section 2.3.3) was used for the baseline
Table 2.1 Parameters used on the CD spectrophotometer.
Parameters

Values
190nm – 260nm

Measurement Range
Scanning Speed

50nm/min

Data Integration Time

4 sec

Bandwidth

2.0nm

Data Pitch

0.1nm

Accumulation

3

Temperature

4°C
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measurement. For the CD measurement, 50µl of the TF-hNPAS2 was added into a clean 0.1mm
pathlength quartz cuvette (JASCO, cat. #J/0559). Using the JASCO Spectra Analysis tool, the CD
ellipticities (mdeg) were converted to molar ellipticities (deg·cm2·dmol-1) by providing the cell
pathlength, concentration, and number of amino acid residues. The resulting spectra were analyzed
with BeStSel41 and JWMVS-529 CD Multivariate SSE program (JASCO). These programs use
default reference sets to deconvolute CD data and elucidate the secondary structure content.

2.5.4 Homology Modeling of TF-hNPAS2
The protein sequence for hNPAS2 was submitted to the I-TASSER structure prediction
server42,43, which provides 5 models from similar templates found in the Protein Data Bank (PDB).
The modelled structures were visualized in the UCSF Chimera program17 and analyzed with the
data retrieved from the circular dichroism spectra.
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Chapter 3 Results
3.1 The Expression and Purification of TF-hNPAS2
3.1.1 Co-expression of TF-hNPAS2 with Chaperones
The successful co-expression of recombinant TF-hNPAS2 and pKJE7 chaperones in E.
coli was achieved (Figure 3.1). To produce similar levels of recombinant protein and molecular
chaperones, their co-expression was optimized by changing the IPTG concentration, arabinose
concentration, expression time, and cell density.

Figure 3.1 Expression optimization of recombinant TF-hNPAS2. A. SDS-PAGE stained by
Coomassie. B. Western Blot using anti-His antibodies. Lane 1 in panel A is the protein marker
(PM) with kDa labeled on the left. Other lanes in panel A and panel B are uninduced (UI) and
IPTG induced (I) samples. Black arrows on the right of both panels point to the expected size of
TF-hNPAS2 (~140kDa), DNAK (~70kDa), and DNAJ (~40kDa).

3.1.2 Affinity Purification
The optimized expression of 4L cultures produced enough soluble recombinant TFhNPAS2 to saturate the 5ml affinity column (Figure 3.2, lane 1 and 2). Most of the contaminants
were eliminated in the washes of 10mM, 20mM, and 40mM imidazole (Figure 3.2, lane 3-5).
Relatively pure recombinant TF-hNPAS2 were obtained on the 60mM, 120mM, and 250mM
15

imidazole elutions (Figure 3.2, lane 6-8), which were named AF60, AF120, and AF250 for
discussion in the following sections. Based on the molecular weight estimation, the persistent
additional band in all elutions was predicted to be the DNAJ chaperone bound to recombinant TFhNPAS2. This bound chaperone could stabilize the folded state of the protein.

Figure 3.2 SDS-PAGE of affinity purification. Lane 1 and 2 are crude (C) and flow through (FT),
respectively. Lane 3 to 9 are fractions from affinity purification with imidazole concentration
labeled above the lane. Black arrows on the right point to the expected size of TF-hNPAS2
(~140kDa) and DNAJ (~40kDa).

3.1.3 Anion-Exchange (AEX) Purification
No significant change in purity has been achieved via AEX purification while the predicted
DNAJ band is still persistent (Figure 3.3). However, the AEX experiments provide interesting
results in further investigations.
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Figure 3.3 SDS-PAGE of AEX purified recombinant TF-hNPAS2. The NaCl concentration is
labelled above each lane. Black arrows on the right point to the expected size of TF-hNPAS2
(~140kDa) and DNAJ (~40kDa).

3.2 Characterization
3.2.1 Size-Exclusion Chromatography (SEC)
For the SEC with the AF120 sample, two overlapping peaks were observed on the
chromatogram. The first peak at an elution volume of 8.49ml corresponds to an estimated
molecular weight of 752kDa, indicating it is a much higher oligomerized form of the recombinant
proteins. The second higher peak eluted with an estimated size of 397kDa at the volume of 10.30
ml (Figure 3.4, blue curve). Based on the SEC and SDS-PAGE results, this higher peak could be
a dimeric

TF-hNPAS2/DNAJ complex. On the contrary, a reversed distribution of the two

peaks was observed in the SEC of the AF250 sample where the first peak was much higher than
the second peak (Figure 3.4, red curve). This indicates the higher oligomerized form of
recombinant proteins are eluted at higher imidazole concentrations in the affinity purification.
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Figure 3.4 SEC chromatogram of TF-hNPAS2 samples. Blue line and orange line are the UV280
absorption for the AF120 and AF250 SEC samples, respectively. The estimated molecular weight
values were labelled above the two peaks.

3.2.2 Dynamic Light Scattering (DLS)
DLS is a common technique used for measuring hydrodynamic size of macromolecules in
solution44. Besides providing the hydrodynamic sizes (diameters) of macromolecules at different
peak locations in the spectra, the quality of the DLS data can be assessed with multiple
parameters45. One of these parameters, the polydispersity index (PDI) describes the particle size
distribution or homogeneity of a sample46. A PDI under 0.1 is highly monodisperse, under 0.3 is
nearly monodisperse, and anything over 0.7 is too polydisperse to be a reliable measurement44,45.
Another parameter, the Y-intercept provides the signal to noise ratio in a DLS measurement47. The
ideal Y-intercept is 1, but values over 0.6 are considered to be acceptable measurements47.
Similar peak locations have been observed in the DLS spectra of the affinity purified
samples, AF60, AF120, and AF250 (Figure 3.5, Panel A) with an insignificant increase in their
size. The estimated hydrodynamic diameters are listed in Table 3.1 together with their quality
control parameters, PDI and y-intercept. The PDI of these samples show they are monodispersed.
Compared to the affinity purified results, the DLS spectra of the AEX samples, AEX253, AEX298,
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and AEX505, show a significant increase in size (Figure 3.5, Panel B). To understand the effect
of salt concentration to the size of the complex in the AEX results, a salt-addition test was
performed. However, no noticeable differences were observed in this test (Figure 3.6, Table 3.2).
A)

B)

Figure 3.5 DLS spectra on affinity (Panel A) and AEX (Panel B) purified TF-hNPAS2.

Table 3.1 DLS measurement profiles on affinity and AEX purified recombinant TF-hNPAS2.
Samples

AF60

AF120

AF250

AEX253 AEX298 AEX505

PDI

0.188

0.148

0.204

0.374

0.182

0.149

Y-intercept

0.849

0.893

0.894

0.746

0.867

0.883

Peak Location (d.nm)

26.42

28.2

32.51

18.53

28.29

40.30

Figure 3.6 DLS spectra of the salt-addition test.
19

Table 3.2 DLS measurement profiles on the salt-addition test.
Parameters

Control

428mM NaCl

605mM NaCl

605mM NaCl (3d)

PDI

0.336

0.331

0.370

0.336

Y-intercept

0.812

0.716

0.752

0.698

Peak Location (d.nm)

20.32

21.71

22.64

22.33

3.2.3 Circular Dichroism (CD)
The CD spectra of the AEX298 samples are comprised of two troughs between 200-230nm
(Figure 3.7). It has been well-established by literature that a ‘w’-shaped spectra between 208222nm contain signals of α-helices whereas a

‘v’-shaped spectra between 217-220nm contain

signals of β-sheets48. The CD spectrum were analyzed by two programs, BeStSel41 and JASCO’s
Multivariate SSE, both of which showed a similar proportion of the α-helical, β-sheets, turns, and
disordered secondary structures (Table 3.5). The percentage of disordered structures, also known
as ‘other’ or ‘irregular’ structures, is estimated to be quite high for the AEX298 sample. These
disordered structures are difficult to be deconvoluted due to the limitations of computational
algorithms49.

Figure 3.7 CD spectra of the recombinant TF-hNPAS2.
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Table 3.3 CD secondary structure estimation by BeStSel and JASCO Multivariate SSE.
α-helix (%)

β-sheet (%)

Turn (%)

Disordered (%)

BeStSel

13.6

33.8

13.2

39.4

JASCO

18.6

31.2

13.1

37.1

3.2.4 Homology Modelling
No structures of hNPAS2 are available. However, it does have a high sequence homology
with murine CLOCK (mCLOCK), whose N-terminal structure of the bHLH-PAS domain has been
determined. A BLAST search of the hNPAS2 amino acid sequence showed a 55% identity to
mCLOCK over an 83% query coverage. Using homologous structure templates in the PDB, the ITASSER structure prediction server provides 5 top models, each with a confidence score (Cscore). The C-score ranges from -5 to 2, where a higher value indicates a greater confidence in the
model42,43. Models 1-5 for hNPAS2 received C-scores of 0.65, -2.43, -2.40, -3.15, and -3.30,
respectively. It is not surprising that 5 of the top 10 threading templates used by the I-TASSER
server for the homology modeling is mCLOCK (PDB 4F3L). The majority of Model 1 has
secondary structures that are closely packed into domains leading to its high C-score. The Nterminal of Model 1 contained 31 α-helices bundled in a curved shape (Figure 3.8, Panel A, red
part) whereas the C-terminal contained two β-sheet rich domains similar to those observed in the
PAS domains (Figure 3.8, Panel A, green part). These two parts are connected by a stretched chain
of 14 amino acids (Figure 3.8, Panel A, blue part). Model 2 and 3 each contained a poorly modelled
N-terminal domain (Figure 3.8, Panel B and C, red parts). The C-terminal regions of these two
models are extended and not well defined, mostly in random coils with very few α-helical content
(Figure 3.8, Panel B and C, green parts). It is noteworthy that the mCLOCK structure (PDB 4F3L)
could not be superposed with any part of Models 1-3. However, the mCLOCK structure was
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superposed well with the N-terminal of Models 4 and 5 with a Cα RMSD less than 1Ȧ across all
319 Cα pairs, even though these two models have lower C-scores (Figure 3.9).
A)

B)

Model 1

C)

Model2

Model3

Figure 3.8 Models 1-3 built by the I-TASSER server. All models are shown in ribbon diagrams
with the N-terminal and C-terminal colored in red and green, respectively. The ribbon diagram
was generated using the UCSF Chimera program17.

A)

B)

Model 4

Model 5

Figure 3.9 Structure comparison between mCLOCK and Model 4 and 5 built by the I-TASSER server.
mCLOCK (PDB 4F3L) is superposed to Model 4 (Panel A) and 5 (Panel B). mCLOCK, Model 4, and
Model 5 were colored in green, red, and pink, respectively. The ribbon diagram and the superposing were
performed using the UCSF Chimera program17.
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Chapter 4. Discussion and Future Work
4.1 Conformational Changes Observed in AEX and SEC
It has been reported that CLOCK and BMAL1 can homodimerize in solution through their
individual bHLH domains, however these homodimers are less stable than their heterodimers
which are established through the intermolecular contact of PAS domains11. Another study of
human PER2c also showed multiple oligomeric states displaying different thermal stabilities in
solution without the presence of the CRY protein50. These results support the two oligomerizations
of hNPAS2 observed in the SEC.
The SEC results show that the samples with higher imidazole concentration elute a greater
proportion of the larger complex compared to the elutions with lower imidazole concentration. On
the contrary, DLS does not show significant size differences of the affinity purified protein
complex eluted with different imidazole concentrations. This can be explained by the resolution
limit of DLS that might not differentiate the size differences in the two complexes. It can be further
supported by the two overlapping peaks in the SEC. Therefore, the sample subjected to the DLS
measurement is a mixture of two complexes with different size. The size estimated by DLS is an
average from both complexes. Furthermore, the SEC buffers contain DTT which could also affect
the oligomerization as seen in a previous study of circadian proteins50.
When the mixture of desalted AF60 and AF120 were loaded to the AEX column, three
distinguished fractions at 253mM, 298mM, and 505mM NaCl with significant size differences
were measured by DLS. This further supports that the affinity purified samples are a mixture of
different oligomerized TF-hNPAS2/DNAJ with different surface charges. The salt-addition test
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demonstrates no transformation between these different oligomers, indicating they might be crosslinked, as suggested in another study of circadian protein, hPER2c50.

4.2 CD Results and Homology Modelling
The far-UV CD data estimated the majority of the recombinant protein do not have
secondary structure content, consistent with 4 of the 5 homology models provided by the ITASSER server. The C-terminal of these 4 models are largely unstructured indicating there is no
reliable template to build the model.

4.3 Conclusion and Future Work
So far, very few structures are available for circadian rhythm proteins, due to the fact that
they are dynamic regulatory factors with a high possibility of containing flexible structures.
Unfortunately, the structure determination of full-length circadian proteins will be challenging and
time consuming. In this study, recombinant TF-hNPAS2 was successfully expressed with
molecular chaperones. The protein was purified and characterized using different techniques. SEC
and DLS data showed purified recombinant protein might have different oligomerization. CD and
homology modelling indicate the C-terminal regions of hNPAS2 might be flexible without
secondary structures.
All the results mentioned above will pave the way for future investigations, including the SEC
of AEX purified samples with or without DTT. It would also be interesting to study tag-less
hNPAS2 using CD and DLS. This will require digestion trials and further purification to remove
the TF tag. Because hNPAS2 is a DNA-binding protein, a heparin column can be used for its
purification or for DNA-binding assays using E-box elements. Purified hNPAS2 with high
homogeneity can also be subjected to structural studies using X-ray crystallography or Cryo-EM.
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Determination of the 3D structure of hNPAS2 will provide much-needed information to
understand its role in the TTFL. Knowledge about the molecular mechanism of the circadian
rhythm will facilitate the development of therapeutic strategies against related diseases.
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